HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

942.615

+1.3410.14%

Number of Gainers:6

Number of Losers:10

Number of Flat:1

PE:- -

High:948.140

Open:941.072

Low:931.273

Close:941.274

Volume:467.94M

Turnover:3.97B

Market Cap:638.59B

Float Cap:527.81B

Loading ...

This Sector Is Experiencing a Major Surge

Does FDA-Backed Mpox mRNA Trial and AstraZeneca Tie-Up Recast the Bull Case For CSPC (SEHK:1093)?

Simply Wall St.

Switzerland's DocMorris H1 Revenue Rises on RX Growth, Raises 2026 Outlook

Sweden's Ambea Q2 Sales Beat Estimates on Higher Occupancy

Press Release: Ping an Good Doctor Announces 2026 Interim Results

CSPC Pharma Says NMPA Accepts NDA for KN026 and Hb1801 for Advanced Breast Cancer

New Push to Boost Spending Targets County-Level Markets: What's Behind the Shift?

Ping An Healthcare's First-Half Results Released: Corporate Wellness Segment Shows Steady Growth, AI Full-Process Support Boosts High-Quality Development

Prenetics Global Q2 Revenue Jumps on AI Brand Growth

Ping an Healthcare Names Yougang Zhu Chairman in Board Reshuffle

CSPC Pharma Unit's Breast Cancer Drug Application Granted Priority Review in China

MT Newswires Live

Sinopharm Appoints Yang Binghua to Board Strategy and Investment Committee

Alphamab Oncology Says China NMPA Accepts Anbenitamab NDA for First-Line HER2+ Advanced Breast Cancer

CSPC Pharmaceutical - Kn026 and Hb1801 Combination Previously Granted Breakthrough Therapy Designation by Nmpa

THOMSON REUTERS

CSPC Pharmaceutical - Nda Indication: First-Line Treatment of Unresectable or Metastatic Her2-Positive Breast Cancer

THOMSON REUTERS

China's Ping an Healthcare H1 Revenue Profit Jumps on Corporate Client Base Expansion

China Traditional Chinese Medicine Holdings Schedules Board Meeting to Review Interim Results

Ping an Healthcare and Technology H1 Net Income Attributable RMB 219.3 Million

THOMSON REUTERS

AH Premium Rankings Unveiled: August 18 Market Close Data

Baiyunshan Pharmaceutical's Unit Gets Macao Drug Regulator's Nod for Cefazolin Sodium for Injection

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK1515/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":942.61523,"timestamp":1787299686774,"preClose":941.2742,"halted":0,"volume":467937535,"delay":0,"changeRate":0.001425,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":1.341064,"latestTime":"08-21 16:00:00","open":941.0721,"high":948.1404,"low":931.27325,"amount":3968572485,"amplitude":0.017919,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"pbRate":1.422618,"peRate":17.199147,"turnoverRate":0.006194,"increases":6,"decrements":10,"flats":1,"marketCap":638593959040,"floatMarketCap":527805996800},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":948.1404,"amplitude":0.017919,"preClose":941.2742,"low":931.27325,"pbRate":"1.422618","latestPrice":942.61523,"volume":467937535,"delay":0,"open":941.0721,"prevYearClose":1190.107,"prevWeekClose":912.416,"prevMonthClose":925.972,"prevQuarterClose":802.777,"fiveDayClose":912.416,"twentyDayClose":904.53,"sixtyDayClose":944.634,"secType":"PLATE","market":"HK","turnoverRate":0.006194,"peRate":17.199147,"marketCap":638593959040,"floatMarketCap":527805996800,"timestamp":1787299686774,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":6,"down":10,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1166888801","title":"This Sector Is Experiencing a Major Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1166888801","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166888801?lang=en_us&edition=fundamental","pubTime":"2026-08-19 14:00","pubTimestamp":1787119253,"startTime":"0","endTime":"0","summary":"Since the technology sector cooled off in July, the innovative drug industry chain has taken the lead in market performance. The sector has risen considerably, with leading player Wuxi AppTec...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1574","MEDX","IBBQ","BK1161","LNGR","BK1515","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480614","title":"Does FDA-Backed Mpox mRNA Trial and AstraZeneca Tie-Up Recast the Bull Case For CSPC (SEHK:1093)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480614","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480614?lang=en_us&edition=fundamental","pubTime":"2026-08-19 13:12","pubTimestamp":1787116367,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group recently reported three developments: U.S. FDA approval to begin clinical trials for its mpox mRNA vaccine, a US$10,000,000 milestone payment from AstraZeneca tied to their small-molecule collaboration, and a joint venture with AstraZeneca to build a biologics manufacturing facility in Shijiazhuang, China.\nTogether, these moves expand CSPC’s innovative vaccine and drug pipeline while pushing its manufacturing and quality systems further onto the global stage.\nWe’ll...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/does-fda-backed-mpox-mrna-trial-and-astrazeneca-tie-up-recas","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/does-fda-backed-mpox-mrna-trial-and-astrazeneca-tie-up-recas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BZ08YS42.EUR","LU1960683339.HKD","LU2039709279.SGD","BK4588","LU0326950275.SGD","LU1807302812.USD","BK1515","LU0314109678.HKD","01093","IE00BZ08YR35.GBP","LU1152091168.USD","IE0008368742.USD","LU0880133367.SGD","LU1993786604.SGD","IE00B5MMRT66.SGD","BK1191","LU0315179316.USD","IE00BZ08YT58.USD","LU1226287529.USD","LU1226287792.SGD","LU1226287875.USD","IE00B031HY20.USD","LABU","KURE","BK4585","LU0072913022.USD","BK1521","LU1008478684.HKD","LU0140636845.USD","SG9999004220.SGD","LU1226288170.HKD","IE0008369823.USD","LU1813983027.USD","LU1226288253.USD","LU1328277881.USD","LU0501845795.SGD","LU0067412154.USD","LU1152091754.HKD","IE00B543WZ88.USD","LU1951186391.HKD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660144444","title":"Switzerland's DocMorris H1 Revenue Rises on RX Growth, Raises 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2660144444","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660144444?lang=en_us&edition=fundamental","pubTime":"2026-08-19 13:11","pubTimestamp":1787116306,"startTime":"0","endTime":"0","summary":"Switzerland's DocMorris H1 revenue rises on RX growth, raises 2026 outlookOverviewSwitzerland online pharmacy's H1 external revenue rose 12.5% yr/yrAdjusted EBITDA loss narrowed by CHF 17.9 mln compar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL1N44G05G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2495084118.USD","LU0405327148.USD","LU2289578879.USD","SG9999002463.SGD","601318","LU0051755006.USD","LU2399975544.HKD","BK0183","LU1781817850.SGD","LU1969619763.USD","DCGO","LU1979443071.USD","BK0032","BK1219","LU0456827905.SGD","BK1515","BK4196","LU1580142542.USD","HK0000181138.USD","BK1142","LU0405327494.USD","BK0196","LU1934453819.USD","LU1997245094.SGD","BK0070","LU1997244956.HKD","LU1064130708.USD","LU1997245177.USD","LU1064131003.USD","LU2213484517.USD","IE0005HP3H50.USD","BK1571","BK1615","HK0000181112.HKD","LU1655091616.SGD","LU0231483743.USD","LU1146622755.USD","01833","BK0188","BK0012","LU0047713382.USD","LU0117841782.USD","LU2328871848.SGD","LU1794554557.SGD","LU1720050803.USD","LU1820825898.SGD","LU0039217434.USD","BK0175","LU0326950275.SGD","LU1255011170.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660144954","title":"Sweden's Ambea Q2 Sales Beat Estimates on Higher Occupancy","url":"https://stock-news.laohu8.com/highlight/detail?id=2660144954","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660144954?lang=en_us&edition=fundamental","pubTime":"2026-08-19 13:10","pubTimestamp":1787116201,"startTime":"0","endTime":"0","summary":"Sweden's Ambea Q2 sales beat estimates on higher occupancyOverviewSweden care provider's Q2 net sales rose 7% yr/yr, beating analyst expectationsAdjusted EBITA and EPS improved on higher occupancy, op","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL1N44G05B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601318","BK1515","HK0000181112.HKD","LU2495084118.USD","BK1247","LU0117841782.USD","BK1615","LU1064130708.USD","LU1146622755.USD","BK1617","LU1781817850.SGD","BK4196","LU1064131003.USD","BK0012","LU2213484517.USD","BK0175","BK0207","LU1794554557.SGD","BK0028","BK0070","BK0183","BK1571","LU1969619763.USD","SG9999002463.SGD","BK1219","LU0039217434.USD","LU1655091616.SGD","BK0187","LU1255011170.USD","LU1997245177.USD","01833","LU0051755006.USD","LU1979443071.USD","LU1997244956.HKD","LU0210526637.USD","LU0456827905.SGD","LU1720050803.USD","LU1961090484.USD","LU0326950275.SGD","LU1997245094.SGD","LU0047713382.USD","BK0196","DCGO","LU0405327494.USD","LU0405327148.USD","LU1820825898.SGD","LU1934453819.USD","LU2328871848.SGD","LU1580142542.USD","HK0000181138.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660413431","title":"Press Release: Ping an Good Doctor Announces 2026 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660413431","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660413431?lang=en_us&edition=fundamental","pubTime":"2026-08-19 08:48","pubTimestamp":1787100480,"startTime":"0","endTime":"0","summary":"Corporate Health Management Business Grows Steadily; AI Healthcare Empowerment Drives Continued Profitability ImprovementHONG KONG, Aug. 18, 2026 /PRNewswire/ -- Ping An Healthcare and Technology Comp","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLS.SI","BK1142","CFA.SI","BK1219","BK1247","SRU.SI","BK1617","CLR.SI","PAImain","BK4022","BK1615","BK1571","BK4232","SRT.SI","CHAT","BK1515","ARTY","JJJ.SI","VTHR","AGIX","01833","AIPO","R","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660951444","title":"CSPC Pharma Says NMPA Accepts NDA for KN026 and Hb1801 for Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660951444","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660951444?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:22","pubTimestamp":1787066521,"startTime":"0","endTime":"0","summary":"BRIEF-CSPC Pharma Says NMPA Accepts NDA For KN026 And HB1801 For Advanced Breast CancerAug 18 (Reuters)-CSPC PHARMACEUTICAL GROUP LIMITED1093.HK:NMPA ACCEPTS NEW DRUG APPLICATION FOR KN026 AND HB1801 FOR ADVANCED BREAST CANCERFurther company coverage:1093.HK","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F0K4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1951186391.HKD","SG9999004220.SGD","LU1993786604.SGD","LU1960683339.HKD","LU0880133367.SGD","01093","IE00B543WZ88.USD","IE0008369823.USD","IE00BZ08YT58.USD","LU0067412154.USD","LU1813983027.USD","LU1226287529.USD","KURE","LU0315179316.USD","BK1521","LU1328277881.USD","LU0140636845.USD","LU1226287792.SGD","LU1226287875.USD","LU0501845795.SGD","LU1152091168.USD","IE00BZ08YS42.EUR","BK1515","LU2039709279.SGD","LU1807302812.USD","LU1008478684.HKD","IE0008368742.USD","BK1191","LU0072913022.USD","IE00BZ08YR35.GBP","LU0326950275.SGD","LU1226288170.HKD","IE00B5MMRT66.SGD","LU1152091754.HKD","IE00B031HY20.USD","LU1226288253.USD","HK0000165453.HKD","LU0314109678.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108832363","title":"New Push to Boost Spending Targets County-Level Markets: What's Behind the Shift?","url":"https://stock-news.laohu8.com/highlight/detail?id=1108832363","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108832363?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:21","pubTimestamp":1787055700,"startTime":"0","endTime":"0","summary":"A notable consumption gap exists between urban and rural areas, where income gains in rural regions tend to drive spending far more effectively than in cities. On August 18, the Ministry of Commerce,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1142","BK1502","BK1571","HK0000165453.HKD","BK1589","BK1615","BK1515","BK1247","BK1617","BK1584","BK1591","BK1501","BK1189","00241","BK1610"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101580655","title":"Ping An Healthcare's First-Half Results Released: Corporate Wellness Segment Shows Steady Growth, AI Full-Process Support Boosts High-Quality Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1101580655","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101580655?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:58","pubTimestamp":1787054311,"startTime":"0","endTime":"0","summary":"On August 18, Ping An Healthcare and Technology Company Limited (stock abbreviation: Ping An Good Doctor, 01833) released its interim results for the first half of 2026, demonstrating continued...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","BK1515","AIPO","BK1142","BK1219","BK4588","01833","BK1247","BK1571","VXUS","BK1617","VTHR","QTOC","BK4585","KCAI","AGIX","BK1615","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660046461","title":"Prenetics Global Q2 Revenue Jumps on AI Brand Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2660046461","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660046461?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:38","pubTimestamp":1787053121,"startTime":"0","endTime":"0","summary":"Prenetics Global Q2 revenue jumps on AI brand growthOverviewConsumer health company's Q2 revenue rose about 288% yr/yr, driven by IM8 brand growthIM8 revenue marked sixth consecutive record quarter, w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL1N44F0AM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1255011170.USD","BK1615","LU0117841782.USD","LU1794554557.SGD","LU1064130708.USD","BK1142","LU1961090484.USD","LU0231483743.USD","LU2148510915.USD","PRE","BK0196","LU1820825898.SGD","LU1720050803.USD","LU1934453819.USD","BK1515","LU0405327148.USD","BK0187","LU0047713382.USD","LU2328871848.SGD","01833","LU2495084118.USD","LU1655091616.SGD","BK4139","LU1997244956.HKD","LU1997245177.USD","LU2289578879.USD","BK0012","IE0005HP3H50.USD","DCGO","BK0070","BK0175","BK1219","LU1146622755.USD","LU0039217434.USD","HK0000181138.USD","LU2213484517.USD","LU1781817850.SGD","SVA","BK0028","601318","LU0210526637.USD","LU2399975544.HKD","LU1580142542.USD","LU1997245094.SGD","BK0207","LU1064131003.USD","LU1969619763.USD","BK1247","SG9999002463.SGD","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660464840","title":"Ping an Healthcare Names Yougang Zhu Chairman in Board Reshuffle","url":"https://stock-news.laohu8.com/highlight/detail?id=2660464840","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660464840?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:29","pubTimestamp":1787052562,"startTime":"0","endTime":"0","summary":"Ping An Healthcare names Yougang Zhu chairman in board reshufflePing An Healthcare and Technology will replace its board chair and refresh its board and committee line-up effective Aug. 19, 2026.Youga","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL1PzKw2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456827905.SGD","LU1781817850.SGD","BK1615","LU1226287529.USD","LU1255011170.USD","01177","601318","LU0405327148.USD","01833","BK0070","LU1997244956.HKD","LU1969619763.USD","LU1993786604.SGD","BK0032","BK0278","SG9999002463.SGD","LU1820825898.SGD","BK1521","LU0501845795.SGD","LU1934453819.USD","BK1571","LU1146622755.USD","LU2148510915.USD","LU0047713382.USD","LU1580142542.USD","LU1997245177.USD","BK1515","LU0067412154.USD","LU0231483743.USD","IE00BZ08YT58.USD","LU1961090484.USD","LU0880133367.SGD","BK4504","BK0187","000001","IE00BZ08YR35.GBP","LU1794554557.SGD","LU","LU1046422090.SGD","BK4526","LU2289578879.USD","BK0012","LU0117841782.USD","BK0188","IE00B0JY6N72.USD","HK0000165453.HKD","BK1142","BK0028","IE00BZ08YS42.EUR","BK0207"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660461809","title":"CSPC Pharma Unit's Breast Cancer Drug Application Granted Priority Review in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2660461809","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660461809?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:50","pubTimestamp":1787050221,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  said the new drug application for Anbenitamab in combination with its Docetaxel for Injection  was accepted by China's National Medical Products Administration.The drug, co-developed by unit Shanghai JMT-BIO Technology and Jiangsu Alphamab Oncology for the first-line treatment of advanced breast cancer, was also included in the priority review procedure.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1951186391.HKD","HK0000165453.HKD","BK1191","LU0314109678.HKD","LU0067412154.USD","01093","IE00BZ08YS42.EUR","IE0008369823.USD","LU1226288170.HKD","LU1328277881.USD","LU1226287529.USD","LU1807302812.USD","LU1226287875.USD","LU1960683339.HKD","LU1008478684.HKD","BK1521","IE00BZ08YT58.USD","LU1226287792.SGD","LU1226288253.USD","LU0140636845.USD","LU2039709279.SGD","LU0072913022.USD","LU0315179316.USD","LU1813983027.USD","LU1993786604.SGD","LU0326950275.SGD","KURE","IE00B5MMRT66.SGD","LU0501845795.SGD","SG9999004220.SGD","IE00B543WZ88.USD","LU0880133367.SGD","IE0008368742.USD","IE00B031HY20.USD","LU1152091754.HKD","BK1515","IE00BZ08YR35.GBP","LU1152091168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660413469","title":"Sinopharm Appoints Yang Binghua to Board Strategy and Investment Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2660413469","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660413469?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:31","pubTimestamp":1787049072,"startTime":"0","endTime":"0","summary":"Sinopharm appoints Yang Binghua to board strategy and investment committeeSinopharm reshuffled board committee memberships effective Aug. 18, 2026.Executive director Yang Binghua joined the strategy a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL9nj7y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1500","LU0640798160.USD","LU1115378108.SGD","01099","BK1515","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660146646","title":"Alphamab Oncology Says China NMPA Accepts Anbenitamab NDA for First-Line HER2+ Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660146646","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660146646?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:01","pubTimestamp":1787047294,"startTime":"0","endTime":"0","summary":"Alphamab Oncology says China NMPA accepts Anbenitamab NDA for first-line HER2+ advanced breast cancerChina’s NMPA accepted an NDA for anbenitamab (KN026) plus albumin-bound docetaxel HB1801 in first-l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL8jzLgj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","09966","LU1152091754.HKD","LU1226287875.USD","IE00B031HY20.USD","KURE","LU1008478684.HKD","LU1152091168.USD","IE00BZ08YS42.EUR","LU1951186391.HKD","SG9999004220.SGD","LU0072913022.USD","LU1960683339.HKD","LU0501845795.SGD","LU1813983027.USD","LU1993786604.SGD","LU0315179316.USD","HK0000165453.HKD","BK1191","LU0880133367.SGD","IE00BZ08YR35.GBP","LU1226287792.SGD","LU1807302812.USD","IE00BZ08YT58.USD","BK1515","LU1226288253.USD","LU0314109678.HKD","LU1226288170.HKD","LU2039709279.SGD","LU1226287529.USD","LU1328277881.USD","IE00B5MMRT66.SGD","01093","LU0067412154.USD","BK1574","IE0008368742.USD","IE00B543WZ88.USD","BK1161","BK1521","LU0140636845.USD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483466","title":"CSPC Pharmaceutical - Kn026 and Hb1801 Combination Previously Granted Breakthrough Therapy Designation by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483466","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660483466?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:01","pubTimestamp":1787047263,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F01I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2039709279.SGD","LU1008478684.HKD","BK1521","LU0072913022.USD","LU1226288170.HKD","LU1993786604.SGD","LU0501845795.SGD","01093","LU0067412154.USD","LU1152091168.USD","LU1226287792.SGD","LU0326950275.SGD","LU1807302812.USD","LU0315179316.USD","LU0880133367.SGD","LU1813983027.USD","IE00B5MMRT66.SGD","IE0008369823.USD","BK1515","IE0008368742.USD","LU1226287529.USD","LU1951186391.HKD","LU1226288253.USD","LU0314109678.HKD","IE00BZ08YT58.USD","LU0140636845.USD","LU1328277881.USD","IE00B031HY20.USD","LU1226287875.USD","SG9999004220.SGD","IE00B543WZ88.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","LU1152091754.HKD","LU1960683339.HKD","KURE","HK0000165453.HKD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660466107","title":"CSPC Pharmaceutical - Nda Indication: First-Line Treatment of Unresectable or Metastatic Her2-Positive Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660466107","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660466107?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:01","pubTimestamp":1787047263,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F01I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0315179316.USD","LU1960683339.HKD","IE00B031HY20.USD","LU0326950275.SGD","LU1226287875.USD","LU1226288253.USD","LU1993786604.SGD","LU0314109678.HKD","01093","LU1813983027.USD","LU2039709279.SGD","BK1521","LU0140636845.USD","IE00BZ08YS42.EUR","LU1807302812.USD","BK1515","IE00BZ08YR35.GBP","LU1328277881.USD","HK0000165453.HKD","LU0880133367.SGD","LU0072913022.USD","LU1152091754.HKD","LU1008478684.HKD","BK1191","IE0008368742.USD","LU1951186391.HKD","LU1226287792.SGD","LU1226288170.HKD","IE0008369823.USD","LU1226287529.USD","LU1152091168.USD","LU0501845795.SGD","IE00BZ08YT58.USD","IE00B5MMRT66.SGD","SG9999004220.SGD","IE00B543WZ88.USD","KURE","LU0067412154.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660465834","title":"China's Ping an Healthcare H1 Revenue Profit Jumps on Corporate Client Base Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2660465834","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660465834?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:17","pubTimestamp":1787044662,"startTime":"0","endTime":"0","summary":"China's Ping An Healthcare H1 revenue profit jumps on corporate client base expansionOverviewChina digital health platform's interim H1 revenue fell 0.7% yr/yr to RMB2.48 blnProfit attributable to sha","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nL1N44F081:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2289578879.USD","LU1794554557.SGD","IE00BGHQDM52.EUR","LU1720050803.USD","LU1934453819.USD","SVA","LU2213484517.USD","LU1064130708.USD","LU1961090484.USD","SG9999015986.USD","IE0005HP3H50.USD","BK0188","LU0405327148.USD","LU1997244956.HKD","BK1515","LU1146622755.USD","BK1247","BK0196","LU2148510915.USD","BK0070","LU1997245177.USD","BK1219","SNYR","LU1997245094.SGD","IE00BMCWC346.EUR","BK0183","LU0047713382.USD","00867","LU0456827905.SGD","BK4196","LU1781817850.SGD","BK1571","LU0117841782.USD","DCGO","BK0012","SG9999002463.SGD","BK1615","BK4183","01833","LU0456846285.SGD","LU1820825898.SGD","LU2328871848.SGD","LU0039217434.USD","BK4139","HK0000181138.USD","BK0187","LU2495084118.USD","601318","LU1064131003.USD","LU0051755006.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660646315","title":"China Traditional Chinese Medicine Holdings Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660646315","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660646315?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:00","pubTimestamp":1787043607,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine Holdings schedules board meeting to review interim resultsChina Traditional Chinese Medicine Holdings will hold a board meeting on Aug. 28, 2026 to review interim re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL819K4v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1515","BK1606","00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660463699","title":"Ping an Healthcare and Technology H1 Net Income Attributable RMB 219.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660463699","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660463699?lang=en_us&edition=fundamental","pubTime":"2026-08-18 16:57","pubTimestamp":1787043455,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nPLX428KRB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1142","BK1571","BK1617","BK1515","BK1219","BK1247","01833","BK1615"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162248813","title":"AH Premium Rankings Unveiled: August 18 Market Close Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1162248813","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162248813?lang=en_us&edition=fundamental","pubTime":"2026-08-18 16:21","pubTimestamp":1787041299,"startTime":"0","endTime":"0","summary":"As of the market close on August 18, data from Zhitong Finance reveals that NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and SINOPEC SSC (01033) hold the top three positions in the A-H share premium...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1193","IE00BVYPNQ40.USD","BK1209","LU0348814723.USD","02846","LU0620787316.HKD","LU0737861699.HKD","LU0516422440.USD","LU1675838814.USD","IE00B031J352.USD","LU0455707207.USD","LU2008162690.USD","LU0327786744.USD","LU0871576103.HKD","LU0648948544.HKD","LU2226246903.HKD","LU1769817179.HKD","LU0828237940.HKD","LU0329678170.USD","BK1576","LU0328353924.USD","02050","BK1183","HK0000320264.USD","SG9999011746.SGD","SGXZ49509284.SGD","02218","LU1282648689.USD","BK1161","LU2476274720.SGD","BK1198","LU1769817096.USD","LU0039217434.USD","BK1141","LU0164865239.USD","BK1594","BK1607","LU1688375341.USD","LU0128522157.USD","03130","LU1328277881.USD","LU1244550494.USD","SG9999002828.SGD","EWH","LU0106252389.USD","BK1149","LU1046422090.SGD","06655","03328","LU0880133367.SGD","BK1610","LU1282649141.HKD","02359","BK1135","02865","LU0791591158.USD","LU1282649810.SGD","LU2125910500.SGD","BK1186","LU0359201885.HKD","BK1614","BK1163","SG9999001093.SGD","IE00BMCWC346.EUR","LU0456827905.SGD","LU0501845795.SGD","BK1214","LU1504937902.USD","IE00B29SXG58.USD","02691","BK1171","SG9999001226.SGD","LU0543330566.HKD","LU1251922891.USD","LU0149721374.USD","LU0918141887.USD","LU0886674414.USD","LU0431992006.USD","LU1152091168.USD","LU0072913022.USD","LU0029875118.USD","HK0000306685.HKD","LU0348827113.USD","LU0572944931.SGD","LU0640798160.USD","BK1574","LU0561508036.HKD","LU0791590937.USD","01989","03200","LU0210526637.USD","159982","BK1554","LU0348805143.USD","LU0163747925.USD","BK1505","LU1988902786.USD","LU1770034418.SGD","LU0096374516.USD","BK1551","LU0417516738.SGD","LU2148510915.USD","LU1831875114.USD","LU2778985437.USD","LU2264538146.SGD","LU2097828474.EUR","LU0320764755.SGD","LU0516423174.USD","BK1521","LU0307460666.USD","BK1122","LU1211504680.USD","LU0266512127.USD","00187","LU0043850808.USD","LU0231483743.USD","IE0031814852.USD","IE00B3M56506.USD","LU0531971595.HKD","LU1064130708.USD","BK1507","LU0348766576.USD","BK1240","BK1105","BK1560","LU0149534421.HKD","07233","LU0229945570.USD","LU0463099449.HKD","LU0737861772.HKD","LU2399975544.HKD","LU0228659784.USD","LU0589944569.HKD","82846","01033","LU0082770016.SGD","LU1366334578.USD","LU0082770016.USD","LU0244354667.USD","IE00BGHQDM52.EUR","LU1282649067.USD","LU0345780281.USD","688981","02899","BK1514","01108","SG9999004220.SGD","LU1242518857.USD","LU1808992512.USD","LU2476274308.USD","BK1202","LU0469268626.HKD","BK1190","03750","LU0117841782.USD","03308","HK0000306701.USD","LU0314109678.HKD","LU0348767384.USD","LU1880383440.USD","LU0051755006.USD","LU1794554557.SGD","IE00BVYPNP33.GBP","LU2097828805.USD","BK1147","HK0000352382.USD","LU0672654166.SGD","LU0708995583.HKD","BK1515","LU0326950275.SGD","LU0254981946.USD","HK0000320223.HKD","01349","LU0540923850.HKD","LU2294711473.HKD","BK1237","LU0348735423.USD","LU0821914370.USD","LU2039709279.SGD","03143","LU1224709979.USD","LU0531970944.HKD","LU0868486357.SGD","03188","LU0516423091.SGD","LU0488056044.USD","LU0165289439.USD","06951","BK1170","LU0214875030.USD","LU0164939612.USD","IE0034224299.USD","LU0348788117.USD","LU1115378108.SGD","LU0359202008.SGD","BK1592","LU0320764599.SGD","LU0052750758.USD","LU1064131342.USD","LU1188198961.HKD","HK0001040143.USD","SGXZ81163826.USD","02475","LU0509642566.USD","LU0048580855.USD","LU0979878070.USD","00981","LU0140636845.USD","LU0516422366.SGD","BK1191","SG9999014674.SGD","02338","LU0345780521.USD","LU0456854461.SGD","BK1526","IE00BZ08YS42.EUR","06185","IE00B5MMRT66.SGD","LU1008478684.HKD","HK0000352291.HKD","00042","00568","LU1720050803.USD","LU0384037296.USD","LU2097828631.EUR","02827","LU1807302812.USD","LU0370786039.SGD","BK1223","01057","LU0823426480.USD","LU0823426308.USD","06869","IE00BZ08YR35.GBP","03678","IE0008369823.USD","LU2097828557.USD","LU1960683339.HKD","LU0588546209.SGD","LU0634319403.HKD","LU0266512473.USD","LU1064131003.USD","BK1506","LU1105468828.SGD","LU0797268264.HKD","03986","LU2177674079.SGD","IE0032431581.USD","BK1546","06166","06745","BK1562","LU0417516902.SGD","LU0502904849.HKD","IE00B543WZ88.USD","LU0061477393.USD","IE0008368742.USD","LU3063872942.SGD","03968","LU0607220059.USD","LU1242518931.SGD","IE00BF5LJ272.USD","00553","LU0359201612.USD","LU0181495838.USD","LU0543330483.HKD","LU1244550577.SGD","83130","LU1961090484.USD","BK1544","LU0516422952.EUR","LU0918141705.HKD","LU0315179316.USD","00300","LU0828238088.HKD","LU0049853897.USD","IE00B0169L03.USD","IE00B031HY20.USD","LU0269904917.USD","LU1719994722.HKD","BK1564","BK1231","LU0329678337.USD","LU1366334651.USD","SG9999002463.SGD","IE00BYV24P56.USD","LU0348816934.USD","BK1533","BK1522","LU0211977185.USD","LU2242644610.SGD","399300","BK0214","LU0593848301.USD","01812","LU0228367735.SGD","LU1993786604.SGD","LU1303224171.USD","LU1152091754.HKD","IE00BZ08YT58.USD","LU0348825331.USD","LU0890818403.SGD","LU2097828714.EUR","LU1048596156.SGD","83188","LU0287142896.SGD","LU1813983027.USD","SG9999006597.SGD","06613","LU0106959298.USD","BK1249","LU1481107354.HKD","BK1523","LU0862451753.SGD","LU1023057109.AUD","LU0164880469.USD","LU1244550221.USD","BK1110","LU1880383366.USD","LU0449509016.USD","LU0828237510.HKD","LU2045819591.USD","LU1226287529.USD","BK1116","00668","HK0001040168.HKD","BK1144","LU0067412154.USD","BK1583","LU0456846285.SGD","LU0173614495.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660845460","title":"Baiyunshan Pharmaceutical's Unit Gets Macao Drug Regulator's Nod for Cefazolin Sodium for Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2660845460","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660845460?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:34","pubTimestamp":1787031298,"startTime":"0","endTime":"0","summary":"Guangzhou Baiyunshan Pharmaceutical's  unit, Guangzhou Baiyunshan Tianxin Pharmaceutical, received drug registration certificates from Macao's pharmaceutical regulator for cefazolin sodium for injection, according to a Shanghai bourse filing on Tuesday.The drug is used to treat infections in the respiratory tract, urinary tract, skin and soft tissues, bones and other parts of the body.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0183","BK0097","BK0028","00874","BK1606","BK0175","BK1191","BK1521","BK1197","BK0012","BK0188","BK0239","600332","BK0096","BK1515","BK0196","BK0070"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":6,"totalSize":213,"code":"91000000","status":"200"}]}}